Hemant K. Parekh - Publications

Affiliations: 
Pathology Temple University, Philadelphia, PA, United States 
Area:
Molecular Biology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Chen J, Solomides C, Parekh H, Simpkins F, Simpkins H. Cisplatin resistance in human cervical, ovarian and lung cancer cells. Cancer Chemotherapy and Pharmacology. 75: 1217-27. PMID 25894720 DOI: 10.1007/S00280-015-2739-2  0.469
2014 Lai PA, Parekh HK, Lin J, Lai P, Rudic J, Geier SS. P009 Human Immunology. 75: 55. DOI: 10.1016/J.Humimm.2014.08.071  0.34
2014 Geier SS, Lai PA, Lin J, Lai PW, Rudic JL, Parekh HK. P008 Human Immunology. 75: 54. DOI: 10.1016/J.Humimm.2014.08.070  0.318
2010 Chen J, Emara N, Solomides C, Parekh H, Simpkins H. Resistance to platinum-based chemotherapy in lung cancer cell lines Cancer Chemotherapy and Pharmacology. 66: 1103-1111. PMID 20953859 DOI: 10.1007/S00280-010-1268-2  0.526
2010 Pallai R, Simpkins H, Chen J, Parekh HK. The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene. Gene. 459: 11-23. PMID 20338228 DOI: 10.1016/J.Gene.2010.03.006  0.542
2010 Rajash P, Simpkins H, Chen J, Parekh HK. Abstract 4990: Nuclear Factor-Y (NF-Y) regulates the transcription of the human aldo-keto reductase 1C1 (AKR1C1) gene* Cancer Research. 70: 4990-4990. DOI: 10.1158/1538-7445.Am10-4990  0.528
2008 Chen J, Adikari M, Pallai R, Parekh HK, Simpkins H. Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 61: 979-87. PMID 17661040 DOI: 10.1007/S00280-007-0554-0  0.557
2006 Parekh HK, Adikari M, Vennapusa B. Differential partitioning of Galphai1 with the cellular microtubules: a possible mechanism of development of Taxol resistance in human ovarian carcinoma cells. Journal of Molecular Signaling. 1: 3. PMID 17224078 DOI: 10.1186/1750-2187-1-3  0.518
2005 Isordia-Salas I, Manns JM, Sainz I, Parekh H, DeLa Cadena RA. Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line. Thrombosis Research. 116: 533-43. PMID 16181989 DOI: 10.1016/J.Thromres.2005.02.012  0.445
2004 Deng HB, Adikari M, Parekh HK, Simpkins H. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase. Cancer Chemotherapy and Pharmacology. 54: 301-7. PMID 15138708 DOI: 10.1007/S00280-004-0815-0  0.574
2002 Parekh HK, Deng HB, Choudhary K, Houser SR, Simpkins H. Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochemical Pharmacology. 63: 1149-58. PMID 11931848 DOI: 10.1016/S0006-2952(02)00850-X  0.493
2002 Deng HB, Parekh HK, Chow KC, Simpkins H. Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. The Journal of Biological Chemistry. 277: 15035-43. PMID 11842089 DOI: 10.1074/Jbc.M112028200  0.587
1997 Parekh H, Pillarisetti K, Kunapuli S, Simpkins H. Isolation of a hamster cDNA homologous to the mouse and human cyclin kinase inhibitory protein p27Kip1. Somatic Cell and Molecular Genetics. 23: 147-51. PMID 9330642 DOI: 10.1007/Bf02679973  0.32
1997 Parekh H, Simpkins H. The transport and binding of taxol. General Pharmacology. 29: 167-72. PMID 9251895 DOI: 10.1016/S0306-3623(97)89716-9  0.448
1997 Parekh H, Wiesen K, Simpkins H. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. Biochemical Pharmacology. 53: 461-70. PMID 9105396 DOI: 10.1016/S0006-2952(97)83383-7  0.499
1996 Parekh H, Simpkins H. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells Cancer Chemotherapy and Pharmacology. 37: 457-462. PMID 8599869 DOI: 10.1007/S002800050412  0.561
1996 Parekh H, Simpkins H. Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system. Biochemical Pharmacology. 51: 301-11. PMID 8573197 DOI: 10.1016/0006-2952(95)02176-0  0.495
Show low-probability matches.